Impact of Mortality-Based Performance Measures on Hospital Pricing: the Case of Colon Cancer Surgeries
NBER Working Paper No. 19447
---- Acknowledgments ----
Research for this paper was supported by award R01CA129766: Pricing of Major Cancer Surgeries: Impact of Insurance, Outcomes, and Severity, from the National Cancer Institute to George Washington University. Preliminary research findings were presented at the AcademyHealth Annual Research Meeting, 2011, and the American Society of Health Economics fourth Biennial Conference, 2012. We wish to thank Martin Brown, Kiyong Jeon and conference participants for comments and suggestions received, and Sungwoog Choi and Ruirui Sun for outstanding research assistance. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research or any sponsoring organization.
---- Disclosure of Financial Relationships for Siran Koroukian ----
Dr. Koroukian is also supported by a) the Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH; and b) grants from the American Cancer Society, and the Ohio Department of Health.
Dr. Koroukian's spouse serves as medical director at and owns shares of American Renal Associates.